Hasil Pencarian - Eytan Breman

  • Menampilkan 1 - 13 hasil dari 13
Perbaiki Hasil
  1. 1
    Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met?

    Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met? oleh Caroline Lonez, Eytan Breman

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Engineering strategies to safely drive CAR T-cells into the future

    Engineering strategies to safely drive CAR T-cells into the future oleh Matteo Rossi, Eytan Breman

    Diterbitkan 2024-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    232 NKG2D-based multi-specific CAR T-cells to overcome antigen escape and improve anti-tumor efficacy

    232 NKG2D-based multi-specific CAR T-cells to overcome antigen escape and improve anti-tumor efficacy oleh Eytan Breman, Benjamin Violle, Celine Jacques-Hespel, Jennifer Bolsee, Jerome Marijsse

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    298 A miRNA-based shRNA platform for the easy, safe, and effective generation of allogeneic CAR T-cells

    298 A miRNA-based shRNA platform for the easy, safe, and effective generation of allogeneic CAR T-cells oleh Thủy Nguyễn, Matteo Rossi, Eytan Breman, Fanny Huberty, Celine Jacques-Hespel, Jerome Marijsse

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    297 Improvement of CAR T-cell performance by simultaneous downregulation of multiple co-inhibitory receptors

    297 Improvement of CAR T-cell performance by simultaneous downregulation of multiple co-inhibitory receptors oleh Thủy Nguyễn, Matteo Rossi, Eytan Breman, Fanny Huberty, Celine Jacques-Hespel, Jerome Marijsse

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    231 Differential effects of target ligands and receptor architecture upon NKG2D CAR T cell activation

    231 Differential effects of target ligands and receptor architecture upon NKG2D CAR T cell activation oleh Thủy Nguyễn, Sophie Agaugué, Caroline Lonez, Eytan Breman, Benjamin Violle, Jennifer Bolsee, Jerome Marijsse

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    285 Proof-of-concept of a non-gene editing technology using shRNA down-regulation to engineer and optimize CAR T-cell functionality

    285 Proof-of-concept of a non-gene editing technology using shRNA down-regulation to engineer and optimize CAR T-cell functionality oleh Thủy Nguyễn, Caroline Lonez, Eytan Breman, Fanny Huberty, Celine Jacques-Hespel, Anne Flament, Jennifer Bolsee, Benjamin Demoulin

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Efficient shRNA-based knockdown of multiple target genes for cell therapy using a chimeric miRNA cluster platform

    Efficient shRNA-based knockdown of multiple target genes for cell therapy using a chimeric miRNA cluster platform oleh Matteo Rossi, Mikhail Steklov, Fanny Huberty, Thuy Nguyen, Jérôme Marijsse, Céline Jacques-Hespel, Paul Najm, Caroline Lonez, Eytan Breman

    Diterbitkan 2023-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    146 Evolving Mutliplexed shRNA to generate tailored CAR T cell therapy

    146 Evolving Mutliplexed shRNA to generate tailored CAR T cell therapy oleh David Gilham, Hannes Iserentant, Eytan Breman, Fanny Huberty, Nancy Ramelot, Mikhail Steklov, Benjamin Lecalve, Jerome Marijse, Celine Jacques-Hespel

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Uptake of HLA Alloantigens via CD89 and CD206 Does Not Enhance Antigen Presentation by Indirect Allorecognition

    Uptake of HLA Alloantigens via CD89 and CD206 Does Not Enhance Antigen Presentation by Indirect Allorecognition oleh Eytan Breman, Jurjen M. Ruben, Kees L. Franken, Mirjam H. M. Heemskerk, Dave L. Roelen, Frans H. Claas, Cees van Kooten

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    107 Armoring NKG2D CAR T cells with IL-18 improves in vivo anti-tumor activity

    107 Armoring NKG2D CAR T cells with IL-18 improves in vivo anti-tumor activity oleh David Gilham, Thủy Nguyễn, Amélie Velghe, Hannes Iserentant, Eytan Breman, Ann-Sophie Walravens, Isabelle Gennart, Benjamin Violle, Fanny Huberty, Nancy Ramelot, Laure Twyffels, Emilie Gauthy

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    NKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient

    NKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient oleh David A. Sallman, Jason Brayer, Elizabeth M. Sagatys, Caroline Lonez, Eytan Breman, Sophie Agaugué, Bikash Verma, David E. Gilham, Frédéric F. Lehmann, Marco L Davila

    Diterbitkan 2018-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Overcoming Target Driven Fratricide for T Cell Therapy

    Overcoming Target Driven Fratricide for T Cell Therapy oleh Eytan Breman, Benjamin Demoulin, Sophie Agaugué, Sebastien Mauën, Alexandre Michaux, Lorraine Springuel, Julien Houssa, Fanny Huberty, Céline Jacques-Hespel, Céline Marchand, Jérôme Marijsse, Thuy Nguyen, Nancy Ramelot, Benjamin Violle, Dorothée Daro, Peter De Waele, David E. Gilham, Valérie Steenwinckel

    Diterbitkan 2018-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: